Skip to main content

Symptomkontrolle

  • Chapter
  • First Online:
Palliativmedizin
  • 1735 Accesses

Zusammenfassung

Neben Schmerzen können Palliativpatienten unter einer Reihe anderer, ebenso belastender Beschwerden leiden, zu denen auch die Atemnot zählt. Atemnot ist zuerst ein subjektives Gefühl, dessen Schwere somit nur Patienten selbst beurteilen können. Eine sorgfältige Ursachensuche ist angezeigt. Ebenso können Übelkeit und Erbrechen verschiedene Ursachen haben, die etwa im Verdauungstrakt selbst liegen oder durch Stoffwechselentgleisungen ausgelöst werden, durch cerebrale Veränderungen hervorgerufen werden, oder nicht selten einfach als Nebenwirkungen von Medikamenten entstehen. Ein häufiges Problem stellt die intestinale Obstipation und/oder Obstruktion dar, zu deren Behandlung individuell angepasste Behandlungskonzepte existieren. Intestinale Obstruktion und Hyperkalzämie können zu einer schweren Symptomlast führen, die differenziert anzugehen ist. Häufig und sehr belastend für Patienten, Angehörige und Betreuungsteam ist das terminale Delir, für dessen Behandlung mehrere Medikamente zur Verfügung stehen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 49.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Adams L, Chronos N, Lane G, Guz A (1985) The measurement of breathlessness induced in normal subjects: validity of two scaling techniques. Clin Sci (Lond) 69:7–16

    Article  CAS  PubMed  Google Scholar 

  • Akechi T, UchitomiY OH (1996) Usage of haloperidol for delirium in cancer patients. Support Cancer Care 4:390–392

    Article  CAS  Google Scholar 

  • Allard P, Lamontagne C, Bernard P, Trenblay C (1999) How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients. J Pain Symptom Manage 17:256–265

    Article  CAS  PubMed  Google Scholar 

  • Alt-Epping B, Sitte T, Nauck F, Radbruch L (2010) Sedierung in der Palliativmedizin. Z Palliativmed 11:112–122

    Article  Google Scholar 

  • American Psychiatric Association (1994) Diagnostic and statistical Manual of Mental disorders. APA, Washington DC

    Google Scholar 

  • Anti M, Pignataro G, Armuzzi A et al (1998) Water supplementation enhances the effect of high fiber diet on stool frequency and laxative consumption in adult patients with functional constipation. Hepatogastroenterology 45:727

    CAS  PubMed  Google Scholar 

  • AWMF (2013) S2k-Leitlinie Chronische Obstipation, aktueller Stand: 02/2013. Register-Nr. 021/019

    Google Scholar 

  • AWMF (2015) S3-Leitlinie Palliativmedizin für Patienten mit einer nicht heilbaren Krebserkrankung, Version 1.0 – Mai 2015. Register-Nr: 128/001OL

    Google Scholar 

  • Bausewein C, Booth S, Gysels M, Kühnbach R, Higginson IJ (2010) Effectiveness of a hand-held fan for breathlessness: a randomised phase II trial. BMC Palliat Care 9:12. https://doi.org/10.1186/1472-684X-9-22

    Article  Google Scholar 

  • Body JJ, Bartl R, Bruckhardt P et al (1998) Current use of bisphosphonates in oncology. J Clin Oncol 16(12):3890–3899

    Article  CAS  PubMed  Google Scholar 

  • Borg GA (1982) Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14:377–781

    Article  CAS  PubMed  Google Scholar 

  • Breitbart W, Marotty R, Platt M (1996) A double-blind comparison trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 153:231–237

    Article  CAS  PubMed  Google Scholar 

  • Breitbart W (2001) Diagnosis and management of delirium in the terminally ill. In: Portenoy, BE (Hrsg) Topics in Palliative care, Vol 5. Oxford University Press, New York, S 303–321

    Google Scholar 

  • Bruera E, Fainsinger R, Miller M, Kuehn N (1992) The assessment of pain intensity in patients with cognitive failure. J Pain Symp Man 7(5):267–270

    Article  CAS  Google Scholar 

  • Bruera E, Hui D, Dalal S, Torres-Vigil I et al (2013) Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial. J Clin Oncol 31(1):111–118

    Article  PubMed  Google Scholar 

  • Chua TP, Harrington D, Ponikowski P et al (1997) Effects of dihydrocodein on chemosensitivity and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol 29:147–152

    Article  CAS  PubMed  Google Scholar 

  • Currow DC, Coughlan M, Fardell B, Cooney NJ (1997) Use of ondasentron in palliative medicine. J Pain Symptom Manage 13:302–307

    Article  CAS  PubMed  Google Scholar 

  • Currow DC, Quinn S, Agar M et al (2015) Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction. J Pain Symptom Manage 49(5):814–821

    Article  PubMed  Google Scholar 

  • Davis K, Attie M (1991) Management of severe hypercalcaemia. Crit Care Clin 7:175–190

    Article  CAS  PubMed  Google Scholar 

  • Drossman DA (2006) Rome III: The functional gastrointestinal disorders, 3. Aufl. Degnon Associates Inc, McLean, VA

    Google Scholar 

  • Drossman et al (1990) Identificationof subgroups of functiomal gastrointestinal disorders. Gatroenterol Int 3:159–172

    Google Scholar 

  • Emanuel EJ, Fairclough DL, Slutsman J, Emanuel LL (2000) Understanding economic and other burdens of terminal illness: experience of patients and their caregivers. Ann Intern Med 132:451–459

    Article  CAS  PubMed  Google Scholar 

  • Evans KC, Bahnzett RB, Adams L (2002) BOLD fMRI identifies limbic, paralimbic, and cerebellar activation during air hunger. J Neurophysiol 88:1500–1511

    Article  PubMed  Google Scholar 

  • Fainsinger R, McEachern T, Hanson J (1991) Symptome control during the last week of life in a palliative care unit. J Palliative Care 7:5–11

    Google Scholar 

  • Fallon B (1998) Nausea and vomiting unrelated to case treatment. In: Berger AM, Portenoy RK, Weissman DE (Hrsg) Principle and practice of supportive oncology. Lippincott Williams and Wilkins, Philadelphia, S 179–190

    Google Scholar 

  • Fernandez F, Levy J, Mansell P (1989) Management of delirium in terminally ill AIDS patients. Int J Psychiat Med 19:165–172

    Article  CAS  Google Scholar 

  • Feuer DJ, Broadley KE (1999) Systematic review of corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancers. Ann Oncol 10:1035–1040

    Article  CAS  PubMed  Google Scholar 

  • Gaginella TS, Bris P (1978) Laxatives: an update on the mechanism of action. Life Sci 23:1001–1010

    Article  CAS  PubMed  Google Scholar 

  • George J, Crawford D, Lewis T et al (1990) Percutaneous endoscopic gastrostomy: a tow year experience. Med J Aust 152:17–20

    Article  CAS  PubMed  Google Scholar 

  • Glare P, Peirera G, Krsitjanson LJ et al (2001) Systematic review of the efficacy of antiemetic in the treatment of nausea in patients with far-advanced cancer. Support Care Cancer 12:432–440

    Article  Google Scholar 

  • Gonzales-Rosales F, Walsh D (1997) Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol. J Pain Sympton Manage 14(5):311–314

    Article  Google Scholar 

  • Hardy J, Daly S, McQuade B et al (2002) A double-blind, randomized parallel group, multinational, multi-centre study comparing ondansetron 24 mg p. o. with placebo and metoclopramide 10 mf tds p. o. in the treatment of opioid induced nausea and emesis in cancer patients. Support Care Cancer 10:331–336

    Article  Google Scholar 

  • Heath DA (1989) Hypercalcemia of malignancy. BMJ 298:1468–1469

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hestermann U, Backenstrass M, Gekle I et al (2009) Validation of a German version of the Confusion Assessment Method for delirium detection in a sample of acute geriatric patients with a high prevalence of dementia. Psychopathology 42(4):270–276

    Article  PubMed  Google Scholar 

  • McCarthyM HI (1989) Measuring symptoms in terminal cancer: are pain and dyspnea controlled? J R Soc Med 82:264–266

    Article  Google Scholar 

  • Holmes S (1989) Use of a modified symptom distress scale in assessment of the cancer patient. Int J Nurs Stud 26:69–7932

    Article  CAS  PubMed  Google Scholar 

  • Inouye B, Bogardus S Jr, Charpentier P et al (1999) A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 340(9):669–676

    Article  CAS  PubMed  Google Scholar 

  • Johnson MJ, McDonagh TA, Harkness A et al (2001) Morphine for the relief of breathlessness in patients with chronic heart failure-a pilot study. Eur J Heart Fail 4:753–756

    Article  Google Scholar 

  • Kovacs C, MacDonald S, Chik C, Bruera E (1995) Hypercalcemia of malignancy in the palliative care patient: a treatment strategy. J Pain Symptom Manage 10:224–232

    Article  CAS  PubMed  Google Scholar 

  • Lawlor P, Gagnon B, Mancini I et al (2001) The occurrence, causes and outcome of delirium in advanced cancer patients: a prospective study. Arch Int Med 160:786–794

    Article  Google Scholar 

  • Leupoldt A, Dahme B (2005) Cortical substrates for the perception of dyspnea. Chest 128(1):345–354

    Article  Google Scholar 

  • Light RW, Muro JR, Sato RI et al (1989) Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 139:126–133

    Article  CAS  PubMed  Google Scholar 

  • Lowler P (2002) Delirium and dehydration: Some fluid for thought? Support Care Cancer 195:835–839

    Google Scholar 

  • MacKintosh D (2016) Olanzapine in the management of difficult to control nausea and vomiting in a palliative care population: A case series. J Palliat Med 19:87–90

    Article  PubMed  Google Scholar 

  • Major P (2001) Use of zeolendroic acid, a novel, highly potent bisphosphonate, for treatment of hypercalcemia of malignancy. Oncologist 7:481–491

    Article  Google Scholar 

  • Manning HL, Schwartzstein RM (1995) Pathophysiology of dyspnea. N Engl J Med 333:1547–1553

    Article  CAS  PubMed  Google Scholar 

  • Massie M, Holland J, Glass E (1983) Delirium in terminally ill cancer patients. Am J Psychiatry 140:1048–1050

    Article  CAS  PubMed  Google Scholar 

  • Mazzocatto C, Buclin T, Rapin CH (1999) The effects of morphine on dyspnea on ventilator function in elderly patients with advanced cancer: a randomized double-blind controlled trial. Annal Oncol 10:1511–1014

    Article  Google Scholar 

  • Menza M, Murray G, Holmes V (1988) Controlled study of extrapyramidal reactions in the management of delirious medically ill patients: Intravenous Haldol versus Haldol plus benzodiazepines. Heart Lung 17:2318–2341

    Google Scholar 

  • Mercadante S, Avola G, Maddaloni S et al (1996) Octreotide prevents the pathological alterations of bowl obstruction in cancer patients. Support Care Cancer 4:393–394

    Article  CAS  PubMed  Google Scholar 

  • Mercadante S, De Conno F, Ripamonti C (1995) Propofol in terminal care. J Pain Symptom Manage 10:639–642

    Article  CAS  PubMed  Google Scholar 

  • Mercadante S, Spoldi CA et al (1993) Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliat Med 7:295–299

    Article  CAS  PubMed  Google Scholar 

  • Morita T, Hyodo I, Yoshimi T et al (2004) Incidence and underlying etiologies of bronchial secretion in terminally ill cancer patients: a multicenter, prospective, observational study. J Pain symptom Manage 27:533–539

    Article  PubMed  Google Scholar 

  • Morita T, Tsunoda J, Inoue S et al (1999) Perception and decision-making on rehydration of terminally ill cancer patients and family members. Am J Hosp Palliat Care 16:509–516

    Article  CAS  PubMed  Google Scholar 

  • Moyle J (1995) The use of propofol in palliative medicine. J Pain Symptom Manage 10:643–646

    Article  CAS  PubMed  Google Scholar 

  • Muers MF, Round CE (1993) Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organization Thoracic Group. Thorax 48:339–343

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nash Smyth E, Conti I, Wooldridge JE et al (2015) Frequency of skeletal-related events and associated health care resource use and costs in US patients with multiple myeloma. J Med Econ 15:1–26

    Google Scholar 

  • Nellgard P, Bojo L, Cassuto J (1995) Importance of vasoactive intestinal peptide and somatostatin for fluid loss in small bowl obstruction. Scand J Gastroenterol 30:464–469

    Article  CAS  PubMed  Google Scholar 

  • Nelville R, Fielding P, Cambria RP, Modlin I (1991) Vascular responsiveness in obstructive gut. Dis Colon Rectum 4:229–235

    Article  Google Scholar 

  • Oliver D (1985) The use of methotrimeprazine in terminal care. BrJ Clin Pract 39:339–340

    CAS  Google Scholar 

  • Passik S, Cooper M (1999) Complicated delirium in cancer patients successfully treated with olanzapine. J Pain Symptom Manage 7:219–223

    Article  Google Scholar 

  • Patel S, Lyons A, Hosking D (1993) Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use. Drugs 46:594–617

    CAS  PubMed  Google Scholar 

  • Pictus D, Marx MV, Weyman PJ (1988) Chronic intestinal obstruction: value of percutaneous gastrostomy tube placement. Am J Radiol 150:295–297

    Google Scholar 

  • Reuben DB, Mor V (1986) Dyspnea in terminally ill cancer patients. Chest 89:234–326

    Article  CAS  PubMed  Google Scholar 

  • Reynolds JC, Putnam PE (1992) Prokinetic agents. Gastroenterol Clin North Am 21:567–596

    Article  CAS  PubMed  Google Scholar 

  • Ripamonti C, Panzeri C, Groff L et al (2001) The role of somatostatin and octreotide in bowl obstruction: pre-clinical and clinical results. Tumori 87:1–9

    Article  CAS  PubMed  Google Scholar 

  • Sarhill N, Walsh D, Nelson K, Davis M (2001) Evaluation and treatment of cancer related fluid deficits: volume depletion or dehydration. Support Care Cancer 9:408–419

    Article  CAS  PubMed  Google Scholar 

  • Schwartz T, Massand P (2001) The role of atypical antipsychotics in the treatment of delirium. Psychosomatics 43:171

    Article  Google Scholar 

  • Sipahimalami A, Sime RM, Massand P (1997) Treatment of delirium with risperdon. In J Geriatric Psychopharmacol 1:24–26

    Google Scholar 

  • Srivastava M, Brito-Dellan N, Davis MP et al (2003) Olanzapine a s an antiemetic in refractory nausea and vomiting in advanced cancer. J Palliat Med 6:251–255

    Google Scholar 

  • Stark RD, Gambles SA, Lewis JA (1981) Methods to access breathlessness in healthy subjects: a critical evaluation and application to analyze the acute effects of diazepam and promethazin on breathlessness induced by exercise or by exposure to raised levels of carbon dioxide. Clin Sci (Lond) 61:429–439

    Article  CAS  PubMed  Google Scholar 

  • Stiefel F, Kornblith A, Holland J, Coyle N, Breitbart W, Weaver S, Portenoy R (1994) Delirium as a contributing factor to ›crescendo pain: Three case reports. J Pain Symptom Manage 9:44–47

    Article  Google Scholar 

  • Thomas JR, von Guten CH (2006) Dyspnea. In: Bruera E, Higgins IJ, Ripamonti C, von Guten CH (eds) Textbook of palliative medicine. Oxford University Press, S 655–662

    Google Scholar 

  • Twycross R, Back I (1998) Nausea and vomiting in advanced cancer. Eur J Palliat Care 5:39–45

    Google Scholar 

  • Ventafridda V, Ripamonti C, Caraceni A et al (1990a) The management of inoperable gastrointestinal obstruction in terminal cancer patients. Tumori 76:389–393

    Article  CAS  PubMed  Google Scholar 

  • Ventafridda V, Ripamonti C, DeConno F (1990b) Symptom prevalence and control during cancer patients´ last days of life. J Palliat Care 6:7–11

    Article  CAS  PubMed  Google Scholar 

  • Wald A (2000) Constipation. Med Clin North Am 84:1231

    Article  CAS  PubMed  Google Scholar 

  • Williams SG, Wright DJ, Marshall P et al (2002) Safety and potential benefits of low dose diamorphine during exercise in patients with chronic heart failure. Heart 88:1085–1086

    Google Scholar 

  • Woodcock AA, Gross ER, Geddes DM (1981) Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers. Br Med J (Clin Re Ed) 281:343–346

    Article  Google Scholar 

  • Zebraski SE, Kochenash SM, Raffa RB (2000) Lung opioid receptors: pharmacology and possible target for nebulized morphine in dyspnea. Life Sci 66:2221–2231

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Herbert Watzke .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Der/die Autor(en), exklusiv lizenziert an Springer-Verlag GmbH, DE, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Watzke, H. (2023). Symptomkontrolle. In: Husebø, S., Mathis, G., Masel, E.K. (eds) Palliativmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-65768-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-65768-3_5

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-65767-6

  • Online ISBN: 978-3-662-65768-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics